Annals of Oncology Advance Access originally published online on May 9, 2006
Annals of Oncology 2006 17(10):1601; doi:10.1093/annonc/mdl089
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2006 European Society for Medical Oncology
letters to the editor |
Toxic epidermal necrolysis in patients with malignancies
1 University of Rome Tor Vergata, Rome, Italy
2 Burn Centre S. Eugenio Hospital, Rome, Italy
3 University "La Sapienza" of Rome, Rome, Italy
4 Institute CNR for Organ Transplantation and Immunocytology, S.Eugenio Hospital, Rome, Italy
*(E-mail: ggravante@hotmail.com)
| The first 10% of the full text of this article appears below. |
Curigliano and colleagues recently published an interesting letter focusing on the appearance of toxic epidermal necrolysis (TEN) in a breast cancer patient [1]. TEN manifestations started 5 days following the administration of voriconazole given for an invasive pulmonary aspergillosis which followed chemotherapy administration, suggesting the possibility for a